Navigation Links
MarketResearchReports.Biz: Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma And Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019 - New Industry Report
Date:9/12/2013

ss Models of Pharmaceutical and Diagnostics Manufacturers

7.2 Investing in Emerging Economies

Chapter 8 Company Profiles

8.1 Abbott Laboratories

8.1.1 Company Overview

8.1.2 Financial Overview

8.1.3 Product Portfolio

8.1.4 Business Strategies

8.1.5 Recent Developments

8.2 Agendia N.V.

8.2.1 Company Overview

8.2.2 Product Portfolio

8.2.3 Business Strategies

8.2.4 Recent Developments

8.3 Agilent Technologies, Inc.,

8.3.1 Company Overview

8.3.2 Financial Overview

8.3.3 Product Portfolio

8.3.4 Business Strategies

8.3.5 Recent Developments

8.4 Biogenex Laboratories, Inc.

8.4.1 Company Overview

8.4.2 Product Portfolio

8.4.3 Business Strategies

8.4.4 Recent Developments

8.5 Ge Healthcare Ltd.

8.5.1 Company Overview

8.5.2 Financial Overview

8.5.3 Product Portfolio

8.5.4 Business Strategies

8.5.5 Recent Developments

8.6 Genomic Health, Inc.

8.6.1 Company Overview

8.6.2 Financial Overview

8.6.3 Product Portfolio

8.6.4 Business Strategies

8.6.5 Recent Developments

8.7 Laboratory Corporation Of America Holdings (Labcorp)

8.7.1 Company Overview

8.7.2 Financial Overview

8.7.3 Product Portfolio

8.7.4 Business Strategies

8.7.5 Recent Developments

8.8 Life Technologies Corporation

8.8.1 Company Overview

8.8.2 Financial Overview

8.8.3 Product Portfolio

8.8.4 Business Strategies

8.8.5 Recent Developments

8.9 Qiagen N.V.

8.9.1 Company Overview

8.9.2 Financial Overview

8.9.3 Product Portfolio

8.9.4 Business Strategies

8.9.5 Recent Developments

8.10 Resonance Health Analysis Services Pty Ltd.

8.10.1 Company Overview

8.10.2 Product Portfolio

8.10.3 Business Strategies

8.10.4 Recent D
'/>"/>

SOURCE MarketResearchReports.Biz
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Companion Diagnostics Market is Expected to Reach USD 5.6 Billion Globally in 2019: Transparency Market Research
2. Personalized Medicine Makes Its Way to Pets With Cancer: Morphogenesis and SEVO-Med Team up for a Canine Cancer Field Study, First of Its Kind, Side-Effect-Free Process to Treat Companion Animals
3. Life Technologies to Collaborate with Merck Serono for Companion Diagnostics Development and Commercialization
4. Medical Design Excellence Awards Selects Companion 2 Hospital Driver for Powering SynCardia Total Artificial Heart as Silver Winner
5. Empire Genomics Awarded SBIR Phase I Grant from NCI for Companion Diagnostics for Multiple Myeloma
6. Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer
7. Market Access Expert Firm, PRMA Consulting, Launches Companion Diagnostics Handbook
8. PrimeraDx to Co-Develop Companion Diagnostics with Quest Diagnostics
9. Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies
10. QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies
11. QIAGEN Gains Rights to Genomic Biomarkers for Lung, Brain and Other Cancers to Expand its Pipeline of Companion Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 GEA Niro Soavi the ... laboratory homogenizer, the PandaPLUS 2000, which is ideal for ... and cell disruption . This compact laboratory homogenizer ... juices, liquid food, food additives and ingredients as well ...
(Date:1/22/2015)... Crystal Diagnostics (CDx) Xpress System, a rapid ... AOAC-PTM Certifications for the six non-O157 Shiga toxin-producing E. coli ... to as STEC or the “Big-6”) as well as Escherichia ... per 325 g of raw ground beef and raw beef ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Selexis SA, ... mammalian Research Cell Banks (RCBs) used for drug discovery ... Cell Banks will include Next-Generation Sequencing (NGS) ... architecture de-risks biologic manufacturing by ensuring the integrity of ...
(Date:1/22/2015)... Mass. , Jan. 22, 2015   GenoSpace , a ... of tools to enable the broad use of genomic, imaging ... announced the appointment of Michelle Munson , CEO of ... director. Logo - http://photos.prnewswire.com/prnh/20150122/170713 ...
Breaking Biology Technology:GEA Niro Soavi Announces the PandaPLUS 2000 Homogenizer for Processing New Applications for Nanoemulsions and Cell Disruption 2Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2GenoSpace Expands Board with Appointment of Michelle Munson 2
... Two Milestones Reached in Zonisamide Patent Portfolio -, ... (Nasdaq: OREX ), a biopharmaceutical company focused ... system-related disorders, today,announced the initiation of its first ... of zonisamide plus olanzapine.,The Phase 2a clinical trial, ...
... to be Indicated ... for Use in First-Line Therapy, SEATTLE, ... announced today that it has submitted a supplemental,Biologics License Application ... of Zevalin(R) ([90Y]-ibritumomab tiuxetan) as,consolidation therapy after remission induction in ...
... Laboratories, Inc.,(NYSE: FRX ), an international manufacturer ... 2009 Second Quarter financial results,before the U.S. stock ... that,day, at 10:00 AM EDT, Forest will host ... Chief Operating Officer and Frank Perier, Senior,Vice President-Finance ...
Cached Biology Technology:Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain 2Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain 3Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain 4Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 2Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 3Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 4Cell Therapeutics Submits Supplemental Biologics License Application for Zevalin Use in First-Line Consolidation Therapy 5Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 Second Quarter Earnings 2
(Date:12/22/2014)... , Dec. 22, 2014  The 2014 Holiday Season may ... Acuity Market Intelligence reports that the long anticipated floodgates ... that intensifying demand for smart phones, tablets, and wearable ... market of 2.5 billion users with nearly 4.8 billion ...
(Date:12/19/2014)... 2014   LaunchKey , the first decentralized mobile authentication ... of Things era, today announced the close of $3 ... led by Metamorphic Ventures with participation from ENIAC Ventures, ... others.  LaunchKey has raised $4 million to date, and ...
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric data ... industry leaders such as Intel, Jabra, Atlas, and Scosche ... products. These products will be showcased at CES 2015, ... . "Our partners choose PerformTek ...
Breaking Biology News(10 mins):First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
... NEW ORLEANS (April 17, 2009) Secondhand tobacco smoke ... cardiovascular function of men and women who were exposed ... as 10 minutes, according to a study from the ... that tobacco smoke could possibly harm cardiovascular function. In ...
... genetics in high school has heard of adenine, thymine, guanine ... the DNA code. But those are not the whole story. ... attention to a fifth nucleotide, 5-methylcytosine (5-mC), that sometimes replaces ... genes are expressed. And now there,s a sixth. In ...
... it,s time X got some attention. In the ... female, University of California, Berkeley, biologist Doris Bachtrog and ... chromosome is every bit as interesting as the much-studied, ... origins and benefits of sexual reproduction. "Contrary to ...
Cached Biology News:Smoke from cigarettes, cooking oil, wood, shift male cardiovascular system into overdrive 2Smoke from cigarettes, cooking oil, wood, shift male cardiovascular system into overdrive 3New nucleotide could revolutionize epigenetics 2New nucleotide could revolutionize epigenetics 3New nucleotide could revolutionize epigenetics 4The story of X -- evolution of a sex chromosome 2The story of X -- evolution of a sex chromosome 3The story of X -- evolution of a sex chromosome 4
... 293 cells were cultured in Minimum Essential Medium ... the log phase of growth. In order ... cells were fixed in acetone-methanol. The cells ... coated slide, with each wells surface specifically treated ...
... Microsphere/Microarray Stabilizer is an aqueous solution that ... non-toxic chemicals in a PBS buffer (phosphate ... This product contains a combination of 0.02% ... StabilCoat Plus Stabilizer provides optimum performance ...
... Anti-PSD-95, clone K28/86.2, PDZ Domain ... Immunogen : GST fusion to residues ... 0.01M Tris pH 7.4, 0.075M NaCl ... routinely evaluated by immunoblot on rat ...
... Clarin represents the state-of-the-art in ... for the permanent preservation of immunohistochemical ... (DAB), Vega Red, New Fuchsin, and ... substrates on tissue sections. Clarin can ...
Biology Products: